Cart
sales@molnova.com
NJK14047
CAS No. 1800576-41-3
NJK14047( NJK 14047 )
Catalog No. M12739 CAS No. 1800576-41-3
NJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNJK14047
-
NoteResearch use only, not for human use.
-
Brief DescriptionNJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α.
-
DescriptionNJK14047 is a novel potent, selective p38 MAPK inhibitor with IC50 of 27 nM against p38α, suppresses RSV and influenza A virus replication by inhibiting virus-induced p38 MAPK activation; inhibits RSV- and influenza A-mediated p38 MAPK activation in epithelial cells, decreases viral replication and viral mRNA synthesis; also displays significant anti-HBV activity, efficiently suppresses the secretion of HBV antigens and HBV particles from HBV genome-transfected cells.
-
In Vitro——
-
In Vivo——
-
SynonymsNJK 14047
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptorp38 MAPK
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number1800576-41-3
-
Formula Weight445.515
-
Molecular FormulaC27H27NO5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC1=C(C=C(C=C1)C(=O)NC2CC2)C3=CC=C(C=C3)C(=O)C4=CC=C(C=C4)OCC(CO)O
-
Chemical NameN-cyclopropyl-4'-(4-(2,3-dihydroxypropoxy)benzoyl)-6-methyl-[1,1'-biphenyl]-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kim SY, et al. Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00214-17.
2. Choi MS, et al. Biochem Biophys Res Commun. 2016 Aug 26;477(3):311-6.
3. Heo J, et al. Bioorg Med Chem Lett. 2015 Sep 1;25(17):3694-8.
molnova catalog
related products
-
BMS-751324
BMS-751324 is a novel clinical prodrug of BMS-582949, which is a highly selective p38α MAPK inhibitor with IC50 of 13 nM.
-
DAMGO
DAMGO is an opioid receptor agonist with the ability to affect the locomotive activity in rodents. Possible analgesic agent due to μ-opiod receptor interaction.
-
SM1-71
SM1-71 is a potent multi-targeted acrylamide-modified TAK1 inhibitor that inhibits MKNK2, MAP2K1/2/3/4/6/7, GAK, AAK1, BMP2K, MAP3K7, MAPKAPK5, GSK3A/B, MAPK1/3, SRC, YES1, FGFR1, ZAK (MLTK), MAP3K1, LIMK1 and RSK2.
